Abstract
The VP5 outer capsid protein of African horse sickness virus (AHSV) is cytotoxic when expressed in Spodoptera frugiperda (Sf-9) cells. Secondary structure analysis of the VP5 amino acid sequence of AHSV-9 identified two N-terminal amphipathic α-helices within the first 43 amino acids. Baculovirus expression of N- and C-terminal truncated VP5 proteins in Sf-9 cells indicated that the N-terminal 43 amino acids correlated with low levels of protein expression and with increased membrane permeabilization and cytotoxicity. Exogenous addition of chemically synthesized VP5 peptides indicated that both N-terminal amphipathic α-helices are required for membrane permeabilization of Sf-9 cells. These findings suggest that AHSV VP5 is a membrane-destabilizing protein.
References
Banerjee M, Johnson JE (2008) Activation, exposure and penetration of virally encoded membrane-active polypeptides during non-enveloped virus entry. Curr Protein Pept Sci 9:16–27
Bong DT, Janshoff A, Steinem C, Ghadiri MR (2000) Membrane partitioning of the cleavage peptide in flock house virus. Biophys J 78:839–845
Browne EP, Bellamy AR, Taylor JA (2000) Membrane-destabilizing activity of rotavirus NSP4 is mediated by a membrane-proximal amphipathic domain. J Gen Virol 81:1955–1959
Coetzer JAW, Erasmus BJ (1994) African horse sickness. In: Coetzer JAW, Thomson GR, Tustin RC (eds) Infectious diseases of livestock. Oxford University Press, Cape Town, pp 460–475
Davis MP, Bottley G, Beales LP, Killington RA, Rowlands DJ, Tuthill TJ (2008) Recombinant VP4 of human rhinovirus induces permeability in model membranes. J Virol 82:4169–4174
Decker T, Lohmann-Matthes ML (1988) A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods 115:61–69
Denisova E, Dowling W, LaMonica R, Shaw R, Scarlata S, Ruggeri F, Mackow ER (1999) Rotavirus capsid protein VP5* permeabilizes membranes. J Virol 73:3147–3153
du Plessis M, Nel LH (1997) Comparative sequence analysis and expression of the M6 gene, encoding the outer capsid protein VP5, of African horsesickness virus serotype nine. Virus Res 47:41–49
Epand RM, Shai Y, Segrest JP, Anantharamaiah GM (1995) Mechanisms for the modulation of membrane bilayer properties by amphipathic helical peptides. Biopolymers 37:319–338
Forzan M, Marsh M, Roy P (2007) Bluetongue virus entry into cells. J Virol 81:4819–4827
Guinea R, Carrasco L (1994) Influenza virus M2 protein modifies membrane permeability in E. coli cells. FEBS Lett 343:242–246
Hall TA (1999) BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 41:95–98
Hassan SH, Wirblich C, Forzan M, Roy P (2001) Expression and functional characterization of bluetongue virus VP5 protein: role in cellular permeabilization. J Virol 75:8356–8367
Huismans H (1979) Protein synthesis in bluetongue virus-infected cells. Virology 92:385–396
Korzeniewski C, Callewaert DM (1983) An enzyme-release assay for natural cytotoxicity. J Immunol Methods 64:313–320
Kyte J, Doolittle RF (1982) A simple method for displaying the hydrophobic character of a protein. J Mol Biol 157:105–142
Martinez-Torrecuadrada JL, Diaz-Laviada M, Roy P, Sanchez C, Vela C, Sanchez-Vizcaino JM, Casal JI (1996) Full protection against African horsesickness (AHS) in horses induced by baculovirus-derived AHS virus serotype 4 VP2, VP5 and VP7. J Gen Virol 77:1211–1221
Martinez-Torrecuadrada JL, Langeveld JPM, Venteo A, Sanz A, Dalsgaard K, Hamilton WDO, Meloen RH, Casal JI (1999) Antigenic profile of African horse sickness virus serotype 4 VP5 and identification of a neutralizing epitope shared with bluetongue virus and epizootic hemorrhagic disease virus. Virology 257:449–459
Mertens PPC, Brown F, Sangar DV (1984) Assignment of the genome segments of bluetongue virus type 1 to the proteins which they encode. Virology 135:207–217
Miller MA, Cloyd MW, Liebmann J, Rinaldo CR, Islam KR, Wang SZS, Mietzner TA, Montelaro RC (1993) Alterations in cell permeability by the lentivirus lytic peptide (LLP-1) of HIV-1 transmembrane protein. Virology 196:89–100
Miller MA, Garry RF, Jaynes JM, Montelaro RC (1991) A structural correlation between lentivirus transmembrane proteins and natural cytolytic peptides. AIDS Res Hum Retroviruses 7:511–519
Newton K, Meyer JC, Bellamy AR, Taylor JA (1997) Rotavirus nonstructural glycoprotein NSP4 alters plasma membrane permeability in mammalian cells. J Virol 71:9458–9465
Sambrook J, Russel DW (2001) Molecular cloning: a laboratory manual. Cold Spring Harbor, New York
Sung JH, Shin SA, Park HK, Montelaro RC, Chong YH (2001) Protective effect of glutathione in HIV-1 lytic peptide 1-induced cell death in human neuronal cells. J Neurovirol 7:454–465
Tsai B (2007) Penetration of nonenveloped viruses into the cytoplasm. Annu Rev Cell Dev Biol 23:23–43
Weissenhorn W, Hinz A, Gaudin Y (2007) Virus membrane fusion. FEBS Lett 581:2150–2155
White JM, Delos SE, Brecher M, Schornberg K (2008) Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit Rev Biochem Mol Biol 43:189–219
Wiethoff CM, Wodrich H, Gerace L, Nemerow GR (2005) Adenovirus protein VI mediates membrane disruption following capsid disassembly. J Virol 79:1992–2000
Zhang X, Boyce M, Bhattacharya B, Zhang X, Schein S, Roy P, Zhou ZH (2010) Bluetongue virus coat protein VP2 contains sialic acid-binding domains, and VP5 resembles enveloped virus fusion proteins. Proc Natl Acad Sci USA 107:6292–6297
Acknowledgments
This work was funded by the National Research Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stassen, L., Huismans, H. & Theron, J. Membrane permeabilization of the African horse sickness virus VP5 protein is mediated by two N-terminal amphipathic α-helices. Arch Virol 156, 711–715 (2011). https://doi.org/10.1007/s00705-010-0897-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00705-010-0897-4